Neoadjuvant chemotherapy of triplet regimens of docetaxel/cisplatin/5-FU (DCF NAC) may improve patient prognosis of cStage II/III esophageal squamous cell carcinoma-propensity score analysis
2016 ◽
Vol 64
(4)
◽
pp. 209-215
◽
2016 ◽
Vol 21
(5)
◽
pp. 890-898
◽
2011 ◽
Vol 29
(15_suppl)
◽
pp. 3555-3555
◽
2013 ◽
Vol 107
(2)
◽
pp. 189-194
◽
2013 ◽
Vol 21
(4)
◽
pp. 1166-1174
◽
2017 ◽
Vol 47
(6)
◽
pp. 480-486
◽